Pharmaceutical Technology

JANUARY 5, 2023

The survey results also indicated that drug pricing and reimbursement constraints will be the second biggest concern, hampering the industry’s growth, as indicated by 30% of the surveyed respondents. To adapt is the only way to thrive. Please check your email to download the Report.

Drug Pricing 69

Drug Pricing Vaccines Labelling Communication 69

Pharmaceutical Technology

DECEMBER 9, 2022

There are also strict price controls, which in some cases can limit profitability for manufacturers. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

JANUARY 16, 2023

The topic of inflation overlaps with drug pricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drug prices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Putting Patients First Blog

SEPTEMBER 27, 2024

Here’s a taste of what awaits you: Exclusive NHC Health AI Content: Gain access to cutting-edge research, reports, white papers, and other NHC-produced and affiliated content on a wide range of Health AI topics. Stay informed about the latest advancements and gain valuable insights. appeared first on National Health Council.

Drug Pricing 52

Drug Pricing 52

Pharmaceutical Technology

JANUARY 16, 2023

The topic of inflation overlaps with drug pricing strategy themes. Policymakers are attempting to respond to inflation crises by introducing new frameworks on the regulation of drug prices. Similar echoes are heard in Europe, where pressure to curb price growth will stay a priority.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Drug Channels

FEBRUARY 23, 2021

This valuable new PhRMA white paper explains the follow-the-dollar math for buy-and-bill products at hospitals. The paper also shows a non-340B example.). This paper will help you understand why hospitals fight any reforms to the 340B Drug Pricing Program—and lobby against white bagging.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Independent Pharmacies Online Pharmacies 52

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Documentation 97

Documentation Hospitals Dosage Drug Pricing 97